Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for PaxMedica

    Client Virtual Booth

    PAXMEDICA

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    PaxMedica
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    50 Tice Blvd, Suite A26 Woodcliff Lake, NJ 07677
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.paxmedica.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    PaxMedica To Provide Immediate PAX-101 IV Suramin Access
    PaxMedica To Provide Immediate PAX-101 IV Suramin Access

    https://www.globenewswire.com/news-release/2024/04/23/2867666/0/en/PaxMedica-Responds-to-Emergency-Request-for-IV-Suramin-and-Commits-to-Provide-Immediate-Access-to-PAX-101.html

    GLOBENEWSWIRE
    23 Apr 2024
    Share Share
    PaxMedica Receives Emergency IV Suramin Request from African Health Ministry
    PaxMedica Receives Emergency IV Suramin Request from African Health Ministry

    https://www.globenewswire.com/news-release/2024/04/16/2864119/0/en/PaxMedica-Receives-Emergency-Request-for-IV-Suramin-from-African-Health-Ministry-for-Use-in-Treating-Fatal-Sleeping-Sickness.html

    GLOBENEWSWIRE
    16 Apr 2024
    Share Share
    PaxMedica PAX-101 Milestone, Update on Potential NDA Filing
    PaxMedica PAX-101 Milestone, Update on Potential NDA Filing

    https://www.globenewswire.com/news-release/2024/04/11/2861889/0/en/PaxMedica-Achieves-Key-Milestone-in-the-Development-of-PAX-101-And-Provides-Update-on-Potential-NDA-Submission.html

    GLOBENEWSWIRE
    11 Apr 2024
    Share Share
    PaxMedica Company Presentation Highlighting Innovations in Autism Disorder
    PaxMedica Company Presentation Highlighting Innovations in Autism Disorder

    https://www.globenewswire.com//news-release/2024/03/13/2845411/0/en/PaxMedica-Updated-Company-Presentation-Highlighting-Innovations-in-Autism-Spectrum-Disorder-Treatments.html

    GLOBENEWSWIRE
    13 Mar 2024
    Share Share
    PaxMedica Announces Closing of $7.0 Million Public Offering
    PaxMedica Announces Closing of $7.0 Million Public Offering

    https://www.accesswire.com/viewarticle.aspx?id=809134&lang=en

    ACCESSWIRE
    22 Nov 2023
    Share Share
    PaxMedica Inc. Featured in Syndicated Broadcast Highlighting FDA Type-B Meeting
    PaxMedica Inc. Featured in Syndicated Broadcast Highlighting FDA Type-B Meeting

    https://www.globenewswire.com//news-release/2023/11/17/2782538/0/en/PaxMedica-Inc-Featured-in-Syndicated-Broadcast-Highlighting-FDA-Type-B-Meeting-to-Review-PAX-101-Pivotal-Trial-Data.html

    GLOBENEWSWIRE
    17 Nov 2023
    Share Share
    PaxMedica Announces Third Quarter 2023 Financial Results and Business Update
    PaxMedica Announces Third Quarter 2023 Financial Results and Business Update

    https://www.accesswire.com/viewarticle.aspx?id=803723&lang=en

    ACCESSWIRE
    15 Nov 2023
    Share Share
    PaxMedica Announces Publication of Autism Spectrum Disorder Ph 2 Study Results
    PaxMedica Announces Publication of Autism Spectrum Disorder Ph 2 Study Results

    https://www.accesswire.com/viewarticle.aspx?id=800332&lang=en

    ACCESSWIRE
    07 Nov 2023
    Share Share
    PaxMedica Engages Bourne Partners to Explore Future Monetization of PRV
    PaxMedica Engages Bourne Partners to Explore Future Monetization of PRV

    https://www.globenewswire.com//news-release/2023/11/02/2772324/0/en/PaxMedica-Engages-Bourne-Partners-to-Explore-Future-Monetization-of-Potential-Priority-Review-Voucher-PRV.html

    GLOBENEWSWIRE
    02 Nov 2023
    Share Share
    PaxMedica Acquires Suramin Research Assets from Rediscovery Life Sciences
    PaxMedica Acquires Suramin Research Assets from Rediscovery Life Sciences

    https://www.globenewswire.com//news-release/2023/10/31/2770138/0/en/PaxMedica-Acquires-Suramin-Research-Assets-from-Rediscovery-Life-Sciences-to-Accelerate-NDA-Submission-for-PAX-101.html

    GLOBENEWSWIRE
    31 Oct 2023
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-2024-05-06

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search